Efficiency of 1,5-anhydroglucitol for a useful clinical marker for short-term glycemic control during surgery

Efficiency of 1,5-anhydroglucitol for a useful clinical marker for short-term glycemic control during surgery - 1,5-AG as a new clinical marker for glycemic control in patients with surgery

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000008457

Enrollment

100

Registered

2012-07-30

Start date

2009-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver resection

Interventions

Measurements for plasma 1.5-AG concentration

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with elective liver resection and intensive care after surgery

Exclusion criteria

Exclusion criteria: Patients with intestinal surgery and renal insufficiency

Design outcomes

Primary

Measure	Time frame
Correlation with pre- and post-surgical glycemic state and plasma 1.5-AG concentration	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026